1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	185_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	185_QUEST_clinical_caseMIR	SENT1	-	-
3	58	58		-	-	9-11	185_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	185_QUEST_clinical_caseMIR	SENT1	-	-
5	,	,	Fc	-	-	16-17	185_QUEST_clinical_caseMIR	SENT1	-	-
6	peso	peso	NCMS000	C0043100	calificador	18-22	185_QUEST_clinical_caseMIR	SENT1	-	-
7	130	130	Z	-	-	23-26	185_QUEST_clinical_caseMIR	SENT1	-	-
8	Kg	kg	NCMN000	-	-	27-29	185_QUEST_clinical_caseMIR	SENT1	-	-
9	,	,	Fc	-	-	29-30	185_QUEST_clinical_caseMIR	SENT1	-	-
10	talla	talla	NCFS000	-	-	31-36	185_QUEST_clinical_caseMIR	SENT1	-	-
11	155	155	Z	-	-	37-40	185_QUEST_clinical_caseMIR	SENT1	-	-
12	cm	cm	NCMN000	-	-	41-43	185_QUEST_clinical_caseMIR	SENT1	-	-
13	,	,	Fc	-	-	43-44	185_QUEST_clinical_caseMIR	SENT1	-	-
14	índice	índice	NCMS000	C1305855_1	entidad_observable_1	45-51	185_QUEST_clinical_caseMIR	SENT1	-	-
15	de	de	SPS00	C1305855_2	entidad_observable_2	52-54	185_QUEST_clinical_caseMIR	SENT1	-	-
16	masa	masa	NCFS000	C1305855_3	entidad_observable_3	55-59	185_QUEST_clinical_caseMIR	SENT1	-	-
17	corporal	corporal	AQ0CS0	C1305855_4	entidad_observable_4	60-68	185_QUEST_clinical_caseMIR	SENT1	-	-
18	>	>	Fz	-	-	69-70	185_QUEST_clinical_caseMIR	SENT1	-	-
19	30	30		-	-	71-73	185_QUEST_clinical_caseMIR	SENT1	-	-
20	con	con	SPS00	C0332287	atributo	74-77	185_QUEST_clinical_caseMIR	SENT1	-	-
21	hipertensión	hipertensión	NCFS000	C0020538_1	trastorno_1	78-90	185_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
22	arterial	arterial	NC00SC0	C0020538_2	trastorno_2	91-99	185_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
23	leve	leve	AQ0CS0	C2945599#C0547040#C1282907	calificador	100-104	185_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
24	,	,	Fc	-	-	104-105	185_QUEST_clinical_caseMIR	SENT1	-	-
25	glucemia	glucemia	NCFS000	C2585282	entidad_observable	106-114	185_QUEST_clinical_caseMIR	SENT1	-	-
26	108	108	Z	-	-	115-118	185_QUEST_clinical_caseMIR	SENT1	-	-
27	mg	mg	NCMN000	-	-	119-121	185_QUEST_clinical_caseMIR	SENT1	-	-
28	/	/	Fh	-	-	121-122	185_QUEST_clinical_caseMIR	SENT1	-	-
29	dL	decilitro	NCMN000	C0439241	calificador	122-124	185_QUEST_clinical_caseMIR	SENT1	-	-
30	y	y	CC	C1706368	calificador	125-126	185_QUEST_clinical_caseMIR	SENT1	-	-
31	ausencia	ausencia	NCFS000	C0332197_1	calificador_1	127-135	185_QUEST_clinical_caseMIR	SENT1	-	-
32	de	de	SPS00	C0332197_2	calificador_2	136-138	185_QUEST_clinical_caseMIR	SENT1	-	-
33	edemas	edema	NCMP000	C0013604	anomalía_morfológica#hallazgo#entidad_observable	139-145	185_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
34	en	en	SPS00	C1720294#C0332285	calificador#atributo	146-148	185_QUEST_clinical_caseMIR	SENT1	-	-
35	miembros	miembro	NCMP000	C0015385	estructura_corporal	149-157	185_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
36	inferiores	inferior	AQ0CP0	C0542339#C0205104	calificador	158-168	185_QUEST_clinical_caseMIR	SENT1	I-Estructura_Corporal	-
37	.	.	Fp	-	-	168-169	185_QUEST_clinical_caseMIR	SENT1	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	170-172	185_QUEST_clinical_caseMIR	SENT2	-	-
2	analítica	analítica	NCFS000	-	-	173-182	185_QUEST_clinical_caseMIR	SENT2	-	-
3	de	de	SPS00	C0332285	atributo	183-185	185_QUEST_clinical_caseMIR	SENT2	-	-
4	sangre	sangre	NCFS000	C0005767	sustancia	186-192	185_QUEST_clinical_caseMIR	SENT2	-	-
5	presenta	presentar	VMIP3S0	-	-	193-201	185_QUEST_clinical_caseMIR	SENT2	-	-
6	Cr	creatinina	NC00YL0	C0010294	sustancia	202-204	185_QUEST_clinical_caseMIR	SENT2	-	-
7	2.0	2.0	Z	-	-	205-208	185_QUEST_clinical_caseMIR	SENT2	-	-
8	mg	mg	NCMN000	-	-	209-211	185_QUEST_clinical_caseMIR	SENT2	-	-
9	/	/	Fh	-	-	211-212	185_QUEST_clinical_caseMIR	SENT2	-	-
10	dl	decilitro	NCMN000	C0439241	calificador	212-214	185_QUEST_clinical_caseMIR	SENT2	-	-
11	,	,	Fc	-	-	214-215	185_QUEST_clinical_caseMIR	SENT2	-	-
12	Urea	urea	NCFS000	C0041942	sustancia	216-220	185_QUEST_clinical_caseMIR	SENT2	-	-
13	86	86	Z	-	-	221-223	185_QUEST_clinical_caseMIR	SENT2	-	-
14	mg	mg	NCMN000	-	-	224-226	185_QUEST_clinical_caseMIR	SENT2	-	-
15	/	/	Fh	-	-	226-227	185_QUEST_clinical_caseMIR	SENT2	-	-
16	dl	decilitro	NCMN000	C0439241	calificador	227-229	185_QUEST_clinical_caseMIR	SENT2	-	-
17	,	,	Fc	-	-	229-230	185_QUEST_clinical_caseMIR	SENT2	-	-
18	Alb	albúmina	NC00YL0	C0001924	sustancia	231-234	185_QUEST_clinical_caseMIR	SENT2	-	-
19	3.8	3.8	Z	-	-	235-238	185_QUEST_clinical_caseMIR	SENT2	-	-
20	g_/_l	g/l	NCMP000	C0439294	calificador	239-242	185_QUEST_clinical_caseMIR	SENT2	-	-
21	,	,	Fc	-	-	242-243	185_QUEST_clinical_caseMIR	SENT2	-	-
22	Na	noradrenalina	NC00YL0	C0028351	producto#sustancia	244-246	185_QUEST_clinical_caseMIR	SENT2	-	-
23	142	142		-	-	247-250	185_QUEST_clinical_caseMIR	SENT2	-	-
24	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	251-254	185_QUEST_clinical_caseMIR	SENT2	-	-
25	/	/	Fh	-	-	254-255	185_QUEST_clinical_caseMIR	SENT2	-	-
26	L	l	NCFS000	-	-	255-256	185_QUEST_clinical_caseMIR	SENT2	-	-
27	,	,	Fc	-	-	256-257	185_QUEST_clinical_caseMIR	SENT2	-	-
28	K	k	NCFS000	-	-	258-259	185_QUEST_clinical_caseMIR	SENT2	-	-
29	4	4		-	-	260-261	185_QUEST_clinical_caseMIR	SENT2	-	-
30	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	262-265	185_QUEST_clinical_caseMIR	SENT2	-	-
31	/	/	Fh	-	-	265-266	185_QUEST_clinical_caseMIR	SENT2	-	-
32	L.	l.	NCFS000	-	-	266-268	185_QUEST_clinical_caseMIR	SENT2	-	-
33	En	en	SPS00	C1720294#C0332285	calificador#atributo	269-271	185_QUEST_clinical_caseMIR	SENT2	-	-
34	analítica	analítica	NCFS000	-	-	272-281	185_QUEST_clinical_caseMIR	SENT2	-	-
35	de	de	SPS00	C0332285	atributo	282-284	185_QUEST_clinical_caseMIR	SENT2	-	-
36	orina	orina	NCFS000	C0042036	sustancia	285-290	185_QUEST_clinical_caseMIR	SENT2	-	-
37	.	.	Fp	-	-	290-291	185_QUEST_clinical_caseMIR	SENT2	-	-
38	sedimento	sedimento	NCMS000	C0333562	anomalía_morfológica	292-301	185_QUEST_clinical_caseMIR	SENT2	-	-
39	sin	sin	SPS00	C0332288	atributo	302-305	185_QUEST_clinical_caseMIR	SENT2	-	-
40	alteraciones	alteración	NCFP000	-	-	306-318	185_QUEST_clinical_caseMIR	SENT2	-	-
41	y	y	CC	C1706368	calificador	319-320	185_QUEST_clinical_caseMIR	SENT2	-	-
42	en	en	SPS00	C1720294#C0332285	calificador#atributo	321-323	185_QUEST_clinical_caseMIR	SENT2	-	-
43	orina	orina	NCFS000	C0042036	sustancia	324-329	185_QUEST_clinical_caseMIR	SENT2	-	-
44	de	de	SPS00	C0332285	atributo	330-332	185_QUEST_clinical_caseMIR	SENT2	-	-
45	24	24	Z	-	-	333-335	185_QUEST_clinical_caseMIR	SENT2	-	-
46	h	h	NCMN000	C0439227	calificador	336-337	185_QUEST_clinical_caseMIR	SENT2	-	-
47	proteinuria	proteinuria	NCFS000	C0033687_1	hallazgo_1	338-349	185_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
48	de	de	SPS00	C0332285	atributo	350-352	185_QUEST_clinical_caseMIR	SENT2	-	-
49	6.3	6.3		-	-	353-356	185_QUEST_clinical_caseMIR	SENT2	-	-
50	gr/24	gr/24		-	-	357-362	185_QUEST_clinical_caseMIR	SENT2	-	-
51	h.	h.	NCFS000	-	-	363-365	185_QUEST_clinical_caseMIR	SENT2	-	-
52	Cual	cual	PR0CS000	-	-	366-370	185_QUEST_clinical_caseMIR	SENT2	-	-
53	de	de	SPS00	C0332285	atributo	371-373	185_QUEST_clinical_caseMIR	SENT2	-	-
54	las	el	DA0FP0	-	-	374-377	185_QUEST_clinical_caseMIR	SENT2	-	-
55	siguientes	siguiente	AQ0CP0	C0332282	atributo	378-388	185_QUEST_clinical_caseMIR	SENT2	-	-
56	entidades	entidad	NCFP000	-	-	389-398	185_QUEST_clinical_caseMIR	SENT2	-	-
57	presentará	presentar	VMIF3S0	-	-	399-409	185_QUEST_clinical_caseMIR	SENT2	-	-
58	con	con	SPS00	C0332287	atributo	410-413	185_QUEST_clinical_caseMIR	SENT2	-	-
59	mayor	mayor	AQ0CS0	C0205164#C1704243#C0549177	calificador	414-419	185_QUEST_clinical_caseMIR	SENT2	-	-
60	probabilidad	probabilidad	NCFS000	-	-	420-432	185_QUEST_clinical_caseMIR	SENT2	-	-
61	.	.	Fp	-	-	432-433	185_QUEST_clinical_caseMIR	SENT2	-	-

